SSH recieves today the Australian International design award for its 2nd generation C-Pulse Heart device,smaller, lighter, quieter, easy proceedure, already approved in EU, There is no competition for this low risk and less invasive device, other similar but high risk blood contacting devices will rapidly lose market share once approved, C-Pulse will be the obvious standard of care in hospitals around the world , FDA allready fast tracted C-Pulse for 388 patient trial with re- imbursments approved , I think the FDA are keeping a keen eye on C-Pulse ,look forward to more good news.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $14.73M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $4.1K | 25.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55000 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 13593 | 1 |
View Market Depth
| Last trade - 13.20pm 11/09/2025 (20 minute delay) ? |
| SSH (ASX) Chart |